Analysis of the Cochrane Review: Anti-vascular Endothelial Growth Factor for Prevention of Postoperative Vitreous Cavity Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy. Cochrane Database Syst Rev. 2015;8:CD008214.
Postoperative vitreous hemorrhage is a complication following vitrectomy for proliferative diabetic retinopathy, delaying visual recovery and making fundus examination and disease follow-up more difficult. Anti-vascular endothelial growth factor drugs such as bevacizumab, when injected in the vitreo...
Main Authors: | David Cordeiro Sousa, Inês Leal, João Costa, António Vaz-Carneiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2017-08-01
|
Series: | Acta Médica Portuguesa |
Subjects: | |
Online Access: | http://actamedicaportuguesa.com/revista/index.php/amp/article/view/9437 |
Similar Items
-
Antiangiogenic drugs and advanced proliferative diabetic retinopathy
by: Jefferson Augusto Santana Ribeiro, et al.
Published: (2011-04-01) -
Cirurgia Obstétrica com Risco Hemorrágico Major em Testemunha de Jeová
by: Maria Carp, et al.
Published: (2021-03-01) -
Neovascularização da retina em hemoglobinopatia SC e hemorragia vítrea
by: Maria Teresa B. C. Bonanomi, et al. -
Vitrectomia na síndrome de Terson
by: Marcos Ávila, et al. -
Use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics
by: Daniel Araújo Ferraz, et al.
Published: (2013-02-01)